AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyci Mark M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sunmarker Pharma

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glyci Mark M 80mg/500mg Tablet

Diabetic patients using Metformin/Gliclazide 80mg/500mg tablets should be aware that this dual-action medication manages type 2 diabetes in adults by regulating blood glucose. Administered orally with meals, consistent daily dosing maximizes effectiveness. Dosage is personalized by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as guided by your doctor. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and nausea. Prompt glucose intake (e.g., sugary foods or juice) is vital for hypoglycemia management. Alcohol consumption increases hypoglycemia risk and should be limited. Additional possible side effects are altered taste, diarrhea, abdominal discomfort, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. Pregnant or lactating women must consult their doctor. Regular blood glucose monitoring, along with periodic blood tests assessing complete blood count and liver function, are essential for safe and effective therapy.

Uses of Glyci Mark M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glyci Mark M 80mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the 80mg/500mg Glyci Mark M Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Glyci Mark M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glyci Mark M 80mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyci Mark M 80mg/500mg tablets should be administered with food.

How Glyci Mark M 80mg/500mg Tablet works:

Each Glyci Mark M 80mg/500mg tablet contains gliclazide and metformin, two medications used to manage blood sugar levels in individuals with diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glyci Mark M 80mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glyci Mark M 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening cases, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glyci Mark M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glyci Mark M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glyci Mark M 80mg/500mg tablets. Physician consultation is essential. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyci Mark M 80mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glyci Mark M 80mg/500mg Tablet :

Should you forget to take a Glyci Mark M 80mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyci Mark M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glyci Mark M 80mg/500mg Tablet

Glyci Mark M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glyci Mark M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glyci Mark M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glyci Mark M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glyci Mark M 80mg/500mg Tablets and seek immediate medical attention.
Prolonged Glyci Mark M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glyci Mark M 80mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Their use should also be avoided in individuals with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Glyci Mark M 80mg/500mg tablets is unsafe. This combination may worsen hypoglycemia and raise the risk of lactic acidosis.
Glyci Mark M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glyci Mark M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glyci Mark M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glyci Mark M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large quantities of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue use and seek immediate medical attention.
Prolonged Glyci Mark M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glyci Mark M 80mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol while taking Glyci Mark M 80mg/500mg tablets is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glyci Mark M 80mg/500mg T...
79
MRP 97
18% off